Monthly Archives: August 2012
22 August 2012
The Harp-2 trial is designed to test the hypothesis that patients with a condition called acute lung injury (ALI) will benefit from treatment with a specific daily dose of a drug called simvastatin for up to 28 days.
10 August 2012
Researchers at the SRMRC have begun a trial to test the practicality of the rapid administering of a drug called Cryoprecipitate, to help stop bleeding in patients who have suffered a serious injury. Cryoprecipitate is a drug…
02 August 2012
“We do see a lot of very sick people and it can be quite heartbreaking, but we know that the research we’re doing will help a lot of people in the long run,” says Sister Aisling Clarkson of the work she and her colleagues do to recruit patients to SRMRC studies.